SlideShare ist ein Scribd-Unternehmen logo
1 von 2
Predictive Analytics in Venture Investing
                              Hosted by Correlation Ventures
                                         4-17-2013
Industry Returns
        25 year VC returns: 16.5% mean, 3% median
        Are there “just 15 deals” that matter each year? The data shows that there are 400-600 5x
        returns per vintage (3 yrs) so more like 200/year
        Low (45%) repeat rate of being top quartile in fund returns from one fund to the next
        35% of capital deployed created 45% of winners (>5X returns)
        One third of rounds that were undersubscribed led to one third of the winners
        Winners broadly dispersed by sector stage and manager
        Geographic proximity to portfolio companies does not improve returns, actually the inverse was
        true (surprising! – or maybe not…)

History of Correlation
        Inventor of Falcon (fraud detection backed by Greylock and battery; acquired by Fair Isaac)
        recruited to run analytics, got together with longtime life sciences and tech investors (David
        Coats, Trevor Kienzle)
        30 VCs personally invested including former head of NVCA
        Recruited Steve Caplan and Matt Rosencroft as advisers
        30 funds have provided peer data for exchange for fundraising analysis data
            o Want to be the industry flag bearers to help people raise capital
            o New research emails come out once per quarter.
        Have records for 60,000 financings since '87 (90% of financings and 2/3 of returns)

Investment Process/Parameters
       Decisions in two weeks or less
       Don't repeat diligence that the lead has done; overlay a fast analytical approach - no fly outs
       reqd from mgmt team or customer calls
       Need five documents - 5-10 min process from entrepreneurs
       Vote with lead; tells team what the reserve is
       Can go up to $2M on first check, $4M total (can go as small as $50k)
           o Pay-to-plays not an issue, plans reserves appropriately to follow on but would get
               converted to common if no other choice (doesn’t expect that to happen in too many
               deals and does reserve a slush fund to prevent good deals from running away)
           o Thinks that there is no difference between how much they own and how those
               investments perform
           o Making smaller investments decreases portfolio risk by enabling diversification
               opportunities

Data Processing
       Filtered out: insider rounds, strategic led, non-VC deal, inexperienced VC led (lower quartile by
       activity over five year period)
       Factor model: financing, syndicate, lead (firm and partner)
       Thirty factor empirical weighting; 100 PT scale
o   Need a score of 70 to consider; about 15% of these make it
           o   Then call with lead VC and team
           o   Do background checks and legal work at own expense
                    Looking to ensure unusual factors aren't popping up (ie: criminal; lead VC is
                      mgmt and investor – surprised ALDEA made it through the process!)
                    48 investments as of Friday (pace about 3 per month); 40% of dollars are in life
                      sciences (recent exit: RQx w/ Avalon Ventures, sold to Genentech)
                    Can follow performance of “anti-portfolio” – the deals they screen but pass on
                      (Correlation’s LP’s will be interested in this data)

Good News
      Number of financings has increased (near peak since 2001 bubble)
      Can consider 1650 deals each year - wants to see as many as possible
      Active VC firms bottomed out in 2010
      Capital raised by US VC funds: $21B in 2012
      Returns have improved dramatically 10% (those at 90th percentile) did 5.5x or better last year
          o Mean was 3.1x last year, up from 0.4x post-bubble
          o Driven by lower pre money valuations, higher exit values, more capital efficiency
                    Pre money valuations: 25% reduction since 2004
                    Exit values: 90th percentile exit in 2001 was $50M, in 2021 it was $300M
                    Capital efficiency: $21M in 2004; $18M today (explanation for tech co’s: push
                       off server expenses to amazon)

Weitere ähnliche Inhalte

Was ist angesagt?

Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...
Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...
Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...Quantopian
 
Book presentation: Excess Returns: a comparative study of the methods of the ...
Book presentation: Excess Returns: a comparative study of the methods of the ...Book presentation: Excess Returns: a comparative study of the methods of the ...
Book presentation: Excess Returns: a comparative study of the methods of the ...Frederik Vanhaverbeke
 
Smart Beta - Lessons from the Oracle of Omaha
Smart Beta - Lessons from the Oracle of OmahaSmart Beta - Lessons from the Oracle of Omaha
Smart Beta - Lessons from the Oracle of OmahaCorey Hoffstein
 
Being open (source) in the traditionally secretive field of quant finance.
Being open (source) in the traditionally secretive field of quant finance.Being open (source) in the traditionally secretive field of quant finance.
Being open (source) in the traditionally secretive field of quant finance.Quantopian
 
"Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ...
"Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ..."Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ...
"Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ...Quantopian
 
Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...
Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...
Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...Lamar Van Dusen
 
How important are the rules used to create smart beta portfolios
How important are the rules used to create smart beta portfoliosHow important are the rules used to create smart beta portfolios
How important are the rules used to create smart beta portfoliosRalph Goldsticker
 
Quantopian is Launching a Crowd-sourced Hedge Fund
Quantopian is Launching a Crowd-sourced Hedge FundQuantopian is Launching a Crowd-sourced Hedge Fund
Quantopian is Launching a Crowd-sourced Hedge Fundkelmstrom
 
Staying agile in dynamic markets amit sinha march 2017
Staying agile in dynamic markets amit sinha march 2017Staying agile in dynamic markets amit sinha march 2017
Staying agile in dynamic markets amit sinha march 2017Amit Sinha
 
The State of Risk Management
The State of Risk ManagementThe State of Risk Management
The State of Risk ManagementCorey Hoffstein
 
"Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes...
"Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes..."Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes...
"Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes...Quantopian
 
"Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas...
"Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas..."Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas...
"Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas...Quantopian
 
Algorithmic Finance Meetup: Starmine Short Interest Talk
Algorithmic Finance Meetup: Starmine Short Interest Talk Algorithmic Finance Meetup: Starmine Short Interest Talk
Algorithmic Finance Meetup: Starmine Short Interest Talk Quantopian
 
"Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob...
"Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob..."Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob...
"Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob...Quantopian
 
"Build Effective Risk Management on Top of Your Trading Strategy" by Danielle...
"Build Effective Risk Management on Top of Your Trading Strategy" by Danielle..."Build Effective Risk Management on Top of Your Trading Strategy" by Danielle...
"Build Effective Risk Management on Top of Your Trading Strategy" by Danielle...Quantopian
 
"From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D...
"From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D..."From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D...
"From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D...Quantopian
 
Dual Momentum Investing by Gary Antonacci QuantCon 2016
Dual Momentum Investing by Gary Antonacci QuantCon 2016Dual Momentum Investing by Gary Antonacci QuantCon 2016
Dual Momentum Investing by Gary Antonacci QuantCon 2016Quantopian
 
"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior Lecturer
"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior Lecturer"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior Lecturer
"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior LecturerQuantopian
 
No Silver Bullets Presentation
No Silver Bullets PresentationNo Silver Bullets Presentation
No Silver Bullets PresentationCorey Hoffstein
 

Was ist angesagt? (20)

Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...
Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...
Self-Directed Investing by Akhil Lodha, Co-founder of Sliced Investing, and M...
 
Book presentation: Excess Returns: a comparative study of the methods of the ...
Book presentation: Excess Returns: a comparative study of the methods of the ...Book presentation: Excess Returns: a comparative study of the methods of the ...
Book presentation: Excess Returns: a comparative study of the methods of the ...
 
Smart Beta - Lessons from the Oracle of Omaha
Smart Beta - Lessons from the Oracle of OmahaSmart Beta - Lessons from the Oracle of Omaha
Smart Beta - Lessons from the Oracle of Omaha
 
Being open (source) in the traditionally secretive field of quant finance.
Being open (source) in the traditionally secretive field of quant finance.Being open (source) in the traditionally secretive field of quant finance.
Being open (source) in the traditionally secretive field of quant finance.
 
"Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ...
"Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ..."Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ...
"Opportunities and Pitfalls in Momentum Investing" by Gary Antonacci, Author ...
 
Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...
Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...
Lamar Van Dusen | Optimal Turnover Revisited : Levels Corresponding to Highes...
 
How important are the rules used to create smart beta portfolios
How important are the rules used to create smart beta portfoliosHow important are the rules used to create smart beta portfolios
How important are the rules used to create smart beta portfolios
 
2017 04-16 rafi
2017 04-16 rafi2017 04-16 rafi
2017 04-16 rafi
 
Quantopian is Launching a Crowd-sourced Hedge Fund
Quantopian is Launching a Crowd-sourced Hedge FundQuantopian is Launching a Crowd-sourced Hedge Fund
Quantopian is Launching a Crowd-sourced Hedge Fund
 
Staying agile in dynamic markets amit sinha march 2017
Staying agile in dynamic markets amit sinha march 2017Staying agile in dynamic markets amit sinha march 2017
Staying agile in dynamic markets amit sinha march 2017
 
The State of Risk Management
The State of Risk ManagementThe State of Risk Management
The State of Risk Management
 
"Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes...
"Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes..."Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes...
"Making the Grade: A Look Inside the Algorithm Evaluation Process" by Dr. Jes...
 
"Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas...
"Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas..."Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas...
"Quant Trading for a Living – Lessons from a Life in the Trenches" by Andreas...
 
Algorithmic Finance Meetup: Starmine Short Interest Talk
Algorithmic Finance Meetup: Starmine Short Interest Talk Algorithmic Finance Meetup: Starmine Short Interest Talk
Algorithmic Finance Meetup: Starmine Short Interest Talk
 
"Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob...
"Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob..."Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob...
"Portfolio Optimisation When You Don’t Know the Future (or the Past)" by Rob...
 
"Build Effective Risk Management on Top of Your Trading Strategy" by Danielle...
"Build Effective Risk Management on Top of Your Trading Strategy" by Danielle..."Build Effective Risk Management on Top of Your Trading Strategy" by Danielle...
"Build Effective Risk Management on Top of Your Trading Strategy" by Danielle...
 
"From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D...
"From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D..."From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D...
"From Alpha Discovery to Portfolio Construction: Pitfalls and Solutions" by D...
 
Dual Momentum Investing by Gary Antonacci QuantCon 2016
Dual Momentum Investing by Gary Antonacci QuantCon 2016Dual Momentum Investing by Gary Antonacci QuantCon 2016
Dual Momentum Investing by Gary Antonacci QuantCon 2016
 
"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior Lecturer
"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior Lecturer"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior Lecturer
"Is Momentum Still Relevant for Today’s Markets?" by Anthony Ng, Senior Lecturer
 
No Silver Bullets Presentation
No Silver Bullets PresentationNo Silver Bullets Presentation
No Silver Bullets Presentation
 

Andere mochten auch

2013 HealthTech Conference Notes
2013 HealthTech Conference Notes2013 HealthTech Conference Notes
2013 HealthTech Conference NotesLindsay Meyer
 
The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...
The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...
The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...Lindsay Meyer
 
Collision Forces: Scientific Integrity Meets the Capital Markets
Collision Forces: Scientific Integrity Meets the Capital MarketsCollision Forces: Scientific Integrity Meets the Capital Markets
Collision Forces: Scientific Integrity Meets the Capital MarketsLindsay Meyer
 
May 2013 EHR Market Share
May 2013 EHR Market ShareMay 2013 EHR Market Share
May 2013 EHR Market ShareLindsay Meyer
 
Dummy Cap Table & Returns Analysis - Round B
Dummy Cap Table & Returns Analysis - Round BDummy Cap Table & Returns Analysis - Round B
Dummy Cap Table & Returns Analysis - Round BLindsay Meyer
 
VENTURE CAPITAL FUND Financial Model
VENTURE CAPITAL FUND Financial ModelVENTURE CAPITAL FUND Financial Model
VENTURE CAPITAL FUND Financial ModelManuel Lacarte
 

Andere mochten auch (8)

2013 HealthTech Conference Notes
2013 HealthTech Conference Notes2013 HealthTech Conference Notes
2013 HealthTech Conference Notes
 
The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...
The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...
The Status of the Regulatory and Economic Landscape for Innovation in Big Pha...
 
Collision Forces: Scientific Integrity Meets the Capital Markets
Collision Forces: Scientific Integrity Meets the Capital MarketsCollision Forces: Scientific Integrity Meets the Capital Markets
Collision Forces: Scientific Integrity Meets the Capital Markets
 
$ANF Tear Sheet
$ANF Tear Sheet$ANF Tear Sheet
$ANF Tear Sheet
 
May 2013 EHR Market Share
May 2013 EHR Market ShareMay 2013 EHR Market Share
May 2013 EHR Market Share
 
The #1 Ball in Golf
The #1 Ball in GolfThe #1 Ball in Golf
The #1 Ball in Golf
 
Dummy Cap Table & Returns Analysis - Round B
Dummy Cap Table & Returns Analysis - Round BDummy Cap Table & Returns Analysis - Round B
Dummy Cap Table & Returns Analysis - Round B
 
VENTURE CAPITAL FUND Financial Model
VENTURE CAPITAL FUND Financial ModelVENTURE CAPITAL FUND Financial Model
VENTURE CAPITAL FUND Financial Model
 

Ähnlich wie Predictive Analytics in Venture Investing

Session 3 - Financing opportunities
Session 3 - Financing opportunitiesSession 3 - Financing opportunities
Session 3 - Financing opportunitiesPontus Engstrom
 
Knauss Angel Investing
Knauss  Angel InvestingKnauss  Angel Investing
Knauss Angel InvestingQRCE
 
Funding A Technology Start Up Insights Into The World Of Venture Capital
Funding A Technology Start Up   Insights Into The World Of Venture CapitalFunding A Technology Start Up   Insights Into The World Of Venture Capital
Funding A Technology Start Up Insights Into The World Of Venture CapitalThomas Weithman
 
Skip the J-Curve: An Intro to Venture Capital Secondary
Skip the J-Curve: An Intro to Venture Capital SecondarySkip the J-Curve: An Intro to Venture Capital Secondary
Skip the J-Curve: An Intro to Venture Capital SecondaryDave McClure
 
Chicago nw presentation 5-24-11
Chicago nw presentation   5-24-11Chicago nw presentation   5-24-11
Chicago nw presentation 5-24-11Jeffrey Bussgang
 
Dimension Mill Annual Presentation
Dimension Mill Annual PresentationDimension Mill Annual Presentation
Dimension Mill Annual PresentationDimension Mill
 
How to VC: Creating a VC fund portfolio model
How to VC: Creating a VC fund portfolio modelHow to VC: Creating a VC fund portfolio model
How to VC: Creating a VC fund portfolio modelDave McClure
 
FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...
FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...
FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...FiBAN
 
Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...
Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...
Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...Salesforce Partners
 
Evaluating_Financial_Health
Evaluating_Financial_HealthEvaluating_Financial_Health
Evaluating_Financial_HealthKristy Martinez
 
Positioning to win: 2015 global private equity survey
Positioning to win: 2015 global private equity surveyPositioning to win: 2015 global private equity survey
Positioning to win: 2015 global private equity surveyEY
 
CeBIT Presentation v4, 7May15
CeBIT Presentation v4, 7May15CeBIT Presentation v4, 7May15
CeBIT Presentation v4, 7May15Mathias Kopp
 
Lessons From the 0.3% Highest Performing Private Companies
Lessons From the 0.3% Highest Performing Private CompaniesLessons From the 0.3% Highest Performing Private Companies
Lessons From the 0.3% Highest Performing Private CompaniesTimothy Nordvedt
 
Funding A Medical Device Startup In The Current Economy
Funding A Medical Device Startup In The Current EconomyFunding A Medical Device Startup In The Current Economy
Funding A Medical Device Startup In The Current EconomyMichael Weickert, Ph.D
 
Company Valuation and Metrics – top down or bottom up?
Company Valuation and Metrics – top down or bottom up?Company Valuation and Metrics – top down or bottom up?
Company Valuation and Metrics – top down or bottom up?The Capital Network
 
TCF...CIF..WTF(unding)? How to prepare a winning application
TCF...CIF..WTF(unding)? How to prepare a winning applicationTCF...CIF..WTF(unding)? How to prepare a winning application
TCF...CIF..WTF(unding)? How to prepare a winning applicationTEDCO
 
Auditing and fraud detection using Picalo
Auditing and fraud detection using PicaloAuditing and fraud detection using Picalo
Auditing and fraud detection using PicaloSii Quist
 
Audit,fraud detection Using Picalo
Audit,fraud detection Using PicaloAudit,fraud detection Using Picalo
Audit,fraud detection Using Picaloguest4ea866f
 

Ähnlich wie Predictive Analytics in Venture Investing (20)

Session 3 - Financing opportunities
Session 3 - Financing opportunitiesSession 3 - Financing opportunities
Session 3 - Financing opportunities
 
Knauss Angel Investing
Knauss  Angel InvestingKnauss  Angel Investing
Knauss Angel Investing
 
Funding A Technology Start Up Insights Into The World Of Venture Capital
Funding A Technology Start Up   Insights Into The World Of Venture CapitalFunding A Technology Start Up   Insights Into The World Of Venture Capital
Funding A Technology Start Up Insights Into The World Of Venture Capital
 
Skip the J-Curve: An Intro to Venture Capital Secondary
Skip the J-Curve: An Intro to Venture Capital SecondarySkip the J-Curve: An Intro to Venture Capital Secondary
Skip the J-Curve: An Intro to Venture Capital Secondary
 
Chicago nw presentation 5-24-11
Chicago nw presentation   5-24-11Chicago nw presentation   5-24-11
Chicago nw presentation 5-24-11
 
Dimension Mill Annual Presentation
Dimension Mill Annual PresentationDimension Mill Annual Presentation
Dimension Mill Annual Presentation
 
How to VC: Creating a VC fund portfolio model
How to VC: Creating a VC fund portfolio modelHow to VC: Creating a VC fund portfolio model
How to VC: Creating a VC fund portfolio model
 
FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...
FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...
FiBAN's business angel training "Business Angel Returns" by Robert Wiltbank -...
 
Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...
Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...
Startup Funding Options - From Kickstarter to Venture Capital - Dreamforce 20...
 
Start up valuation methods
Start up valuation methodsStart up valuation methods
Start up valuation methods
 
Evaluating_Financial_Health
Evaluating_Financial_HealthEvaluating_Financial_Health
Evaluating_Financial_Health
 
Survey II Results – Winter/Spring 2010
Survey II Results – Winter/Spring 2010Survey II Results – Winter/Spring 2010
Survey II Results – Winter/Spring 2010
 
Positioning to win: 2015 global private equity survey
Positioning to win: 2015 global private equity surveyPositioning to win: 2015 global private equity survey
Positioning to win: 2015 global private equity survey
 
CeBIT Presentation v4, 7May15
CeBIT Presentation v4, 7May15CeBIT Presentation v4, 7May15
CeBIT Presentation v4, 7May15
 
Lessons From the 0.3% Highest Performing Private Companies
Lessons From the 0.3% Highest Performing Private CompaniesLessons From the 0.3% Highest Performing Private Companies
Lessons From the 0.3% Highest Performing Private Companies
 
Funding A Medical Device Startup In The Current Economy
Funding A Medical Device Startup In The Current EconomyFunding A Medical Device Startup In The Current Economy
Funding A Medical Device Startup In The Current Economy
 
Company Valuation and Metrics – top down or bottom up?
Company Valuation and Metrics – top down or bottom up?Company Valuation and Metrics – top down or bottom up?
Company Valuation and Metrics – top down or bottom up?
 
TCF...CIF..WTF(unding)? How to prepare a winning application
TCF...CIF..WTF(unding)? How to prepare a winning applicationTCF...CIF..WTF(unding)? How to prepare a winning application
TCF...CIF..WTF(unding)? How to prepare a winning application
 
Auditing and fraud detection using Picalo
Auditing and fraud detection using PicaloAuditing and fraud detection using Picalo
Auditing and fraud detection using Picalo
 
Audit,fraud detection Using Picalo
Audit,fraud detection Using PicaloAudit,fraud detection Using Picalo
Audit,fraud detection Using Picalo
 

Mehr von Lindsay Meyer

Negotiating the Deal
Negotiating the DealNegotiating the Deal
Negotiating the DealLindsay Meyer
 
Three-dimensional Ultrasound: Techniques and Applications in Obstetrics
Three-dimensional Ultrasound: Techniques and Applications in ObstetricsThree-dimensional Ultrasound: Techniques and Applications in Obstetrics
Three-dimensional Ultrasound: Techniques and Applications in ObstetricsLindsay Meyer
 
The Science of What's In the Bottle: Factors Which Influence pH of White Wine
The Science of What's In the Bottle: Factors Which Influence pH of White WineThe Science of What's In the Bottle: Factors Which Influence pH of White Wine
The Science of What's In the Bottle: Factors Which Influence pH of White WineLindsay Meyer
 
“Reduction of an Aldehyde or Ketone”
“Reduction of an Aldehyde or Ketone”“Reduction of an Aldehyde or Ketone”
“Reduction of an Aldehyde or Ketone”Lindsay Meyer
 
The Science of What’s in the Bottle: Factors Which Influence pH of White Wine
The Science of What’s in the Bottle: Factors Which Influence pH of White WineThe Science of What’s in the Bottle: Factors Which Influence pH of White Wine
The Science of What’s in the Bottle: Factors Which Influence pH of White WineLindsay Meyer
 
$ANF Valuation Model
$ANF Valuation Model$ANF Valuation Model
$ANF Valuation ModelLindsay Meyer
 
Death prompts a review of gene therapy vector
Death prompts a review of gene therapy vectorDeath prompts a review of gene therapy vector
Death prompts a review of gene therapy vectorLindsay Meyer
 
Prenatal exposure to isotretinoin
Prenatal exposure to isotretinoinPrenatal exposure to isotretinoin
Prenatal exposure to isotretinoinLindsay Meyer
 
Rock Health Demo Day June 2012
Rock Health Demo Day June 2012Rock Health Demo Day June 2012
Rock Health Demo Day June 2012Lindsay Meyer
 
Rock Health Demo Day Notes
Rock Health Demo Day NotesRock Health Demo Day Notes
Rock Health Demo Day NotesLindsay Meyer
 
BoxWorks SuperSession: “The Future of Healthcare and the Cloud”
BoxWorks SuperSession: “The Future of Healthcare and the Cloud”BoxWorks SuperSession: “The Future of Healthcare and the Cloud”
BoxWorks SuperSession: “The Future of Healthcare and the Cloud”Lindsay Meyer
 

Mehr von Lindsay Meyer (11)

Negotiating the Deal
Negotiating the DealNegotiating the Deal
Negotiating the Deal
 
Three-dimensional Ultrasound: Techniques and Applications in Obstetrics
Three-dimensional Ultrasound: Techniques and Applications in ObstetricsThree-dimensional Ultrasound: Techniques and Applications in Obstetrics
Three-dimensional Ultrasound: Techniques and Applications in Obstetrics
 
The Science of What's In the Bottle: Factors Which Influence pH of White Wine
The Science of What's In the Bottle: Factors Which Influence pH of White WineThe Science of What's In the Bottle: Factors Which Influence pH of White Wine
The Science of What's In the Bottle: Factors Which Influence pH of White Wine
 
“Reduction of an Aldehyde or Ketone”
“Reduction of an Aldehyde or Ketone”“Reduction of an Aldehyde or Ketone”
“Reduction of an Aldehyde or Ketone”
 
The Science of What’s in the Bottle: Factors Which Influence pH of White Wine
The Science of What’s in the Bottle: Factors Which Influence pH of White WineThe Science of What’s in the Bottle: Factors Which Influence pH of White Wine
The Science of What’s in the Bottle: Factors Which Influence pH of White Wine
 
$ANF Valuation Model
$ANF Valuation Model$ANF Valuation Model
$ANF Valuation Model
 
Death prompts a review of gene therapy vector
Death prompts a review of gene therapy vectorDeath prompts a review of gene therapy vector
Death prompts a review of gene therapy vector
 
Prenatal exposure to isotretinoin
Prenatal exposure to isotretinoinPrenatal exposure to isotretinoin
Prenatal exposure to isotretinoin
 
Rock Health Demo Day June 2012
Rock Health Demo Day June 2012Rock Health Demo Day June 2012
Rock Health Demo Day June 2012
 
Rock Health Demo Day Notes
Rock Health Demo Day NotesRock Health Demo Day Notes
Rock Health Demo Day Notes
 
BoxWorks SuperSession: “The Future of Healthcare and the Cloud”
BoxWorks SuperSession: “The Future of Healthcare and the Cloud”BoxWorks SuperSession: “The Future of Healthcare and the Cloud”
BoxWorks SuperSession: “The Future of Healthcare and the Cloud”
 

Predictive Analytics in Venture Investing

  • 1. Predictive Analytics in Venture Investing Hosted by Correlation Ventures 4-17-2013 Industry Returns 25 year VC returns: 16.5% mean, 3% median Are there “just 15 deals” that matter each year? The data shows that there are 400-600 5x returns per vintage (3 yrs) so more like 200/year Low (45%) repeat rate of being top quartile in fund returns from one fund to the next 35% of capital deployed created 45% of winners (>5X returns) One third of rounds that were undersubscribed led to one third of the winners Winners broadly dispersed by sector stage and manager Geographic proximity to portfolio companies does not improve returns, actually the inverse was true (surprising! – or maybe not…) History of Correlation Inventor of Falcon (fraud detection backed by Greylock and battery; acquired by Fair Isaac) recruited to run analytics, got together with longtime life sciences and tech investors (David Coats, Trevor Kienzle) 30 VCs personally invested including former head of NVCA Recruited Steve Caplan and Matt Rosencroft as advisers 30 funds have provided peer data for exchange for fundraising analysis data o Want to be the industry flag bearers to help people raise capital o New research emails come out once per quarter. Have records for 60,000 financings since '87 (90% of financings and 2/3 of returns) Investment Process/Parameters Decisions in two weeks or less Don't repeat diligence that the lead has done; overlay a fast analytical approach - no fly outs reqd from mgmt team or customer calls Need five documents - 5-10 min process from entrepreneurs Vote with lead; tells team what the reserve is Can go up to $2M on first check, $4M total (can go as small as $50k) o Pay-to-plays not an issue, plans reserves appropriately to follow on but would get converted to common if no other choice (doesn’t expect that to happen in too many deals and does reserve a slush fund to prevent good deals from running away) o Thinks that there is no difference between how much they own and how those investments perform o Making smaller investments decreases portfolio risk by enabling diversification opportunities Data Processing Filtered out: insider rounds, strategic led, non-VC deal, inexperienced VC led (lower quartile by activity over five year period) Factor model: financing, syndicate, lead (firm and partner) Thirty factor empirical weighting; 100 PT scale
  • 2. o Need a score of 70 to consider; about 15% of these make it o Then call with lead VC and team o Do background checks and legal work at own expense  Looking to ensure unusual factors aren't popping up (ie: criminal; lead VC is mgmt and investor – surprised ALDEA made it through the process!)  48 investments as of Friday (pace about 3 per month); 40% of dollars are in life sciences (recent exit: RQx w/ Avalon Ventures, sold to Genentech)  Can follow performance of “anti-portfolio” – the deals they screen but pass on (Correlation’s LP’s will be interested in this data) Good News Number of financings has increased (near peak since 2001 bubble) Can consider 1650 deals each year - wants to see as many as possible Active VC firms bottomed out in 2010 Capital raised by US VC funds: $21B in 2012 Returns have improved dramatically 10% (those at 90th percentile) did 5.5x or better last year o Mean was 3.1x last year, up from 0.4x post-bubble o Driven by lower pre money valuations, higher exit values, more capital efficiency  Pre money valuations: 25% reduction since 2004  Exit values: 90th percentile exit in 2001 was $50M, in 2021 it was $300M  Capital efficiency: $21M in 2004; $18M today (explanation for tech co’s: push off server expenses to amazon)